ERG rearrangement is present in a subset of transition zone prostatic tumors

被引:49
作者
Falzarano, Sara M. [1 ,2 ]
Navas, Maria [3 ]
Simmerman, Kelly [1 ]
Klein, Eric A. [4 ]
Rubin, Mark A. [5 ]
Zhou, Ming [1 ,4 ]
Magi-Galluzzi, Cristina [1 ,4 ]
机构
[1] Cleveland Clin, Dept Anat Pathol, Pathol & Lab Med Inst, Cleveland, OH 44195 USA
[2] Univ Siena, Dept Pathol & Human Oncol, I-53100 Siena, Italy
[3] Summa Hlth Syst, Dept Pathol, Akron, OH USA
[4] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA
[5] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA
关键词
ERG rearrangement; peripheral zone; prostate cancer; transition zone; TMPRSS2-ERG GENE FUSION; RADICAL PROSTATECTOMY SPECIMENS; PERIPHERAL ZONE; MORPHOLOGICAL FEATURES; CLINICAL-SIGNIFICANCE; CANCER; EXPRESSION; ADENOCARCINOMA; OVEREXPRESSION; CARCINOMA;
D O I
10.1038/modpathol.2010.150
中图分类号
R36 [病理学];
学科分类号
100103 [病原生物学];
摘要
A majority of prostate cancers exhibit a recurrent gene rearrangement involving chromosome 21. In approximately 90% of cases, the rearrangement is characterized by fusion of the androgen-regulated gene TMPRSS2 with the oncogene ERG. A recent study suggested that TMPRSS2-ERG gene fusion is lacking in cancers arising from the transition zone of the prostate. A dominant transition zone cancer was detected in 62/397 (16%) patients who underwent radical prostatectomy at our institution and were reviewed and mapped by a single pathologist. In 46/62 specimens, a secondary tumor was identified in the peripheral zone of the prostate. A tissue microarray containing both transition and peripheral zone tumors was constructed and evaluated for gene fusion analysis. TMPRSS2-ERG fusion status was determined using a multicolor interphase fluorescence in situ hybridization assay for ERG break-apart. The median age of the patients was 59 years. Prostatectomy Gleason score was 6 in 21, 7 in 34, and >= 8 in 7 cases. Median tumor volume was 200 mm(2). TMPRSS2-ERG gene fusion was present in 7/59 (12%) transition zone, and in 12/35 (34%) peripheral zone tumors. Transition zone fusion-positive cases were larger than their negative counterparts. No significant correlation was found between fusion status and Gleason score or pathologic stage. Gene fusion through deletion occurred in 4/7 transition zone and 7/12 peripheral zone tumors. Transition zone prostate cancers are considered biologically and genetically different from peripheral zone tumors. Although ERG rearrangement is more common in peripheral zone tumors, we have detected TMPRSS2-ERG fusion in a subset of transition zone cancers (12%). The lower frequency of gene fusion in transition zone prostate cancer may suggest distinct molecular alterations from peripheral zone tumors and the association with a high tumor volume may indicate a growth advantage for transition zone tumors harboring the gene fusion. Further studies are necessary to confirm this hypothesis. Modern Pathology (2010) 23, 1499-1506; doi:10.1038/modpathol.2010.150; published online 6 August 2010
引用
收藏
页码:1499 / 1506
页数:8
相关论文
共 47 条
[1]
Anterior-predominant prostatic tumors: Zone of origin and pathologic outcomes at radical prostatectomy [J].
Al-Ahmadie, Hikmat A. ;
Tickoo, Satish K. ;
Olgac, Smera ;
Gopalan, Anuradha ;
Scardino, Peter T. ;
Reuter, Victor E. ;
Fine, Samson W. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (02) :229-235
[2]
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma [J].
Albadine, Roula ;
Latour, Mathieu ;
Toubaji, Antoun ;
Haffner, Michael ;
Isaacs, William B. ;
Platz, Elizabeth A. ;
Meeker, Alan K. ;
Demarzo, Angelo M. ;
Epstein, Jonathan I. ;
Netto, George J. .
MODERN PATHOLOGY, 2009, 22 (11) :1415-1422
[3]
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer [J].
Attard, G. ;
Clark, J. ;
Ambroisine, L. ;
Fisher, G. ;
Kovacs, G. ;
Flohr, P. ;
Berney, D. ;
Foster, C. S. ;
Fletcher, A. ;
Gerald, W. L. ;
Moller, H. ;
Reuter, V. ;
De Bono, J. S. ;
Scardino, P. ;
Cuzick, J. ;
Cooper, C. S. .
ONCOGENE, 2008, 27 (03) :253-263
[4]
AUBIN SM, 2010, ASCO 2010 GEN CANC S
[5]
Biochemical recurrence following radical prostatectomy: A comparison between prostate cancers located in different anatomical zones [J].
Augustin, H ;
Erbersdobler, A ;
Graefen, M ;
Fernandez, S ;
Palisaar, J ;
Huland, H ;
Hammerer, P .
PROSTATE, 2003, 55 (01) :48-54
[6]
Transition Zone and Anterior Stromal Prostate Cancers: Zone of Origin and Intraprostatic Patterns of Spread at Histopathology [J].
Bouye, Sebastien ;
Potiron, Eric ;
Puech, Philippe ;
Leroy, Xavier ;
Lemaitre, Laurent ;
Villers, Arnauld .
PROSTATE, 2009, 69 (01) :105-113
[7]
TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions [J].
Cerveira, Nuno ;
Ribeiro, Franclim R. ;
Peixoto, Ana ;
Costa, Vera ;
Henrique, Rui ;
Jeronimo, Carmen ;
Teixeira, Manuel R. .
NEOPLASIA, 2006, 8 (10) :826-832
[8]
Chen ME, 2000, CANCER, V89, P1800, DOI 10.1002/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO
[9]
2-D
[10]
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort [J].
Demichelis, F. ;
Fall, K. ;
Perner, S. ;
Andren, O. ;
Schmidt, F. ;
Setlur, S. R. ;
Hoshida, Y. ;
Mosquera, J-M ;
Pawitan, Y. ;
Lee, C. ;
Adami, H-O ;
Mucci, L. A. ;
Kantoff, P. W. ;
Andersson, S-O ;
Chinnaiyan, A. M. ;
Johansson, J-E ;
Rubin, M. A. .
ONCOGENE, 2007, 26 (31) :4596-4599